RT Journal Article
SR Electronic
T1 A chest-CT and clinical chemistry based flowchart for rapid COVID-19 triage at emergency departments – a multicenter study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.29.20218743
DO 10.1101/2020.10.29.20218743
A1 Steef Kurstjens
A1 Eva-Leonne Göttgens
A1 Bob Smit
A1 Bent Postma
A1 Carl Kluge
A1 Armando van der Horst
A1 Eva H.J. Lamboo
A1 Caroline M.M. Janssen – Te Slaa
A1 Robert Herpers
A1 Yvette C.M. Kluiters-de Hingh
A1 Arthur du Mée
A1 Marjan Veuger
A1 Rob van Marum
A1 Peter de Jager
A1 Marc G. L. M. Elisen
A1 Ron Kusters
A1 Martin Schuijt
A1 Marc H. M. Thelen
YR 2020
UL http://medrxiv.org/content/early/2020/11/03/2020.10.29.20218743.abstract
AB Background Due to the large number of patients with coronavirus disease 19 (COVID-19), rapid diagnosis at the emergency department (ED) is of critical importance. In this study we have developed a flowchart based on two well-known diagnostic methods: the ‘corona-score’ and the ‘CO-RADS’. This flowchart can be used in hospitals that use chest-CT, instead of chest X-ray, for COVID-19 suspected patients at the ED.Methods ED patients (n=1904) from the Jeroen Bosch Hospital, Amphia Hospital, HagaHospital, Elisabeth TweeSteden Hospital, Bernhoven Hospital and Slingeland Hospital were included. A laboratory-based ‘corona-score’, without radiology, called the ‘lab-corona-score’ was combined with a chest-CT based radiology scoring system (CO-RADS), to develop a flowchart. The performance was assessed by sensitivity/specificity analyses using the RT-PCR outcome or the physician’s final diagnosis as golden standard.Results Out of the 1904 patients, 611 (32.1%) patients tested positive for the SARS-CoV-2 virus. The lab-corona-score alone had an AUC of 0.86, a sensitivity of 87% and a specificity of 88% using cut-off values of 0-2 (negative) and 8-10 (positive). Of 255 patients, from the Amphia and Slingeland Hospitals, a CO-RADS score was determined. The flowchart, which combined the ‘CO-RADS’ with the ‘lab-corona-score’, was developed based on data from Slingeland Hospital (sensitivity 97%, specificity 96%). Hereafter, the performance of the flowchart was validated using an independent dataset from Amphia hospital, and reached a sensitivity of 98% and specificity of 93%. A decision could be made in 79% of the patients, which was correct in 95% of the cases.Conclusion This flowchart, based on radiology (CO-RADS) and clinical chemistry parameters (lab-corona-score), results in a rapid and accurate diagnosis of COVID-19 at the ED.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted according to the declaration of Helsinki and Guidelines for Good Clinical Practice. The execution of this retrospective observational study of patient records was approved by the regional Medical Research Ethics Committee (METC Brabant), which declared that the use of anonymized patient data is not subject to the regulations of the WMO (Dutch Medical Research Involving Human Subjects Act). Consent was obtained by an opt-out agreement.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and further information are available upon reasonable request